Update on PACIFIC-2 Phase III trial of Imfinzi concurrently administered with platinum-based chemoradiotherapy in unresectable, Stage III non-small cell lung cancer - AstraZeneca astrazeneca.com Submitted by astrazenecacom1757 on November 15, 2023 at 1:35 AM in business No comments 28